At 7.6% CAGR, the pharmaceutical lipids market size will surpass

Brooklyn, New York, July 18 28, 2022 (GLOBE NEWSWIRE) — Reports and Insights has released a new report titled “Pharmaceutical Lipids Market: Opportunity Analysis and Future Valuation 2022-2030» analyzed by product (simple lipids (triglycerides, waxes), compound lipids (phospholipids, sphignolipids, glycolipids, supholipids), derived lipids (steroids, sterolsulfates, prostaglandins, others), cholesterol, fatty acids, others), by chemical sources (Lipids compounds (1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA), 1,2-dipalmitoyl-sn-glycero-3-phosphate (DPPA), 1,2-distearoyl-sn-glycero-3-phosphate ( DSPA), 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG), 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG), 1,2-distearoyl-sn-glycero-3-phosphoglycerol , By source (synthetic, semi-synthetic, natural), by composition (simple lipids, compound lipids, derived lipids), by application (conventional lipid-based drug delivery systems, drug delivery systems self-emulsifying agents, ry Systems self-microemulsifying agents, liposomes, solid lipid nanoparticles, nanostructured lipid transporters, others), by route of administration (oral (tablet, solution), parenteral (intravenous, intramuscular (vaccines)), topical) and by region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) is expected to grow at a significant CAGR for the period between 2022 and 2030. The Pharmaceutical Lipids Market is expected to reach a worth $5,740.4 min by the end of 2022 and should reach a value of US$10,306.1 million by 2030 with a significant 7.6% CAGR.

Get a sample full PDF copy of the report:
Key insights from market research

  • The Pharmaceutical Lipids Market is expected to reach a value of US$5,740.4M by the end of 2022 and is expected to reach a value of US$10,306.1M by 2030 with a significant CAGR of 7.6% .
  • The simple lipids product type segment in the pharmaceutical lipids market is expected to create an additional opportunity of US$ 2,832.5 million during the forecast period
  • In 2022, the chemical sources segment composed of lipids accounted for the largest market share and is expected to grow at a CAGR of 7.7% during the forecast period.
  • In 2022, the application segment of conventional lipid-based drug delivery systems accounted for a key market share and is expected to grow at a CAGR of 7.5% during the forecast period.
  • The North America region is expected to remain one of the key markets throughout the forecast period (2022-2030) and is further expected to witness significant growth from the pharmaceutical industry.
  • In value, the parental sector of the administration segment should represent more than a third of the market share in 2022

Lipids can be understood as a heterogeneous group of organic compounds which are commonly present in plants, animals as well as microorganisms. They incorporate fats, waxes, sterols and fat-soluble nutrients which are organic molecules. Pharmaceutical lipids have most of their utility as drug excipients for drug formation. The increasing prevalence of chronic diseases among the population, at present, such as cancer and heart and neurological diseases, greatly propels the demand for new drugs and effective drug delivery mechanisms, thus accelerating the demand for lipids pharmaceuticals in world markets.

Growing demand for oral solid drug formulations to propel demand for pharmaceutical lipids worldwide

  • Oral solid dosage forms are the dominant mode of administration in the pharmaceutical industry and are the preferred option for several medications due to their cost-effectiveness and patient compliance. Additionally, using a capsule/tablet for a drug product can provide benefits including physical and chemical stability, the convenience of managing unique brand recognition, and controlled release options.
  • For all these factors, the production volume of solid forms is large, the market is expected to perform well due to long-term growth based on aging population, continued scientific breakthroughs, increasing wealth in emerging markets and industry consolidation.
  • There has been an increase in the demand for oral formulation of solid medications in recent years due to the ease of consumption at all ages. Oral dosage forms generally require more excipients than other forms during the drug manufacturing process. In addition, many patients find it difficult to swallow hard tablets, which is why manufacturers are developing innovative solid oral products such as effervescent tablets, ODGs, lozenges and others. All these aspects are expected to influence the demand for pharmaceutical lipids in the coming years.

In particular, lipids are gaining ground due to their low levels of toxicity. These properties of lipids further contribute to the effective delivery of drugs. Due to this, the global pharmaceutical lipids market is expected to witness significant growth over the coming years. On top of that, according to the American Association of Pharmaceutical Scientists (AAPS), about 90% of drugs in development and 40% of drugs on the market have low water solubility. Based on the presumption, lipid-based preparations and drugs are increasingly common in diagnostics, vaccines, pharmaceuticals, and nutraceuticals. These factors are further estimated to play a major role in accelerating the growth of the global pharmaceutical lipids market over the years. Additionally, increasing adoption of a comprehensive range of natural, semi-synthetic, synthetic, or fully man-made lipids and polymers in the creation of several different dosage forms is further expected to propel the market in the coming years.

See the latest news and developments in the global Pharmaceutical Lipids industry at –

Pharmaceutical Lipids Market Segmentation

The global pharmaceutical lipids market is segmented on the basis of product, chemical sources, sources, composition, application, route of administration and region.

By product

Simple lipids



Compound lipids





Derived lipids


Sterol sulfates




fatty acids


By chemical sources

Compound lipids

1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA)

1,2-dipalmitoyl-sn-glycero-3-phosphate (DPPA)

1,2-distearoyl-sn-glycero-3-phosphate (DSPA)

1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG)

1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG)

1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG)

1, Palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG)


Derived lipids










View Complete TOC & Figures & Graphs of Pharmaceutical Lipids Market Report –

By origin




By membership

Simple lipids

Compound lipids

Derived lipids

By request

Conventional lipid-based drug delivery systems

Self-emulsifying drug delivery systems

Self-microemulsifying drug delivery systems


Solid lipid nanoparticles

Nanostructured lipid transporters


By administration



The solution



Intramuscular (Vaccines)


By region

North America

Latin America


Asia Pacific

Middle East


Pharmaceutical Lipids Market Key Players

Some of the Major Participating Players in the Global Pharmaceutical Lipids Market are:

ABITEC Corporation (ABF Ingredients)


Croda International Plc

Corden Pharma

NOF (Nippon Oil & Fats) Corporation

Cayman Chemical Company

Lipoid GmbH

Nippon Fine Chemical Co. Ltd.

Dishman Group


IOI Oleo GmbH

Stepan Company

Evonik Industries SA

To see the top players, segmentation and other stats of the Pharmaceutical lipids Industry, get a sample report: @

About reports and insights:

Reports and Insights is a leading market research company that offers group research and consulting worldwide. At Reports and Insights, we adhere to client needs and reflect regularly to bring out more valuable and real results for our clients. We are equipped with a strategically strengthened group of researchers and analysts who redefine and stabilize trade polarity in different categorical dimensions of the market.

Previous Loans: Should you opt for an overdraft facility?
Next The TMF office offers agencies more project support